NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections

NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections - 2022. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notes:

• These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables available at https://www.cdc.gov/nndss/data-statistics/index.html. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data at https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
• Notices, errata, and other notes are available in the Notice To Data Users page at https://wonder.cdc.gov/nndss/NTR.html.
• The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.

Footnotes:

*Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.

NNDSS - 表格 1Y. 流行性腮腺炎至新型流感A病毒感染 - 2022年。本表格展示了美国、美国领土以及非美国居民报告的传染病疑似病例。

备注：
• 这是来自国家传染病监测系统（NNDSS）的选定传染病每周病例数据。NNDSS数据由50个州、纽约市、哥伦比亚特区和美国领土报告，并按周以编号表格形式发布，可在https://www.cdc.gov/nndss/data-statistics/index.html查阅。各州卫生部门向CDC提交的每周报告病例可能处于信息持续修订和延迟报告状态。因此，后续周的数据可能反映随着信息的进一步获得而对这些计数所做的更改。表格中的病例数按每周发布的数据呈现。请参阅https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf中的NNDSS临时数据和最终数据解读指南。
• 在数据用户通知页面https://wonder.cdc.gov/nndss/NTR.html中可获取通知、勘误和其他备注。
• 国家报告传染病和条件列表及其国家监测病例定义可在https://ndc.services.cdc.gov/找到。此列表包含了经州和地区流行病学家委员会（CSTE）批准的国家监测立场声明。

脚注：
*2021年和2022年的病例数仅供参考，可能有所变动。病例根据提交给NNDSS的报道管辖区域的居住国分配，如果病例的常住国为美国、美国领土、未知或未报告（即国家未报告）；否则，病例将被分配至“非美国居民”类别。目前并非所有管辖区域或所有条件都报告常住国。有关这些数据的解释，请参阅https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf。
†过去52周的最大值和当年至今累计值是根据条件在该管辖区域可报告的时间段确定的（即可能少于52周的数据或当年至今数据不完整）。
U：不可用 —— 报告管辖区域无法向CDC发送数据或CDC无法处理数据。
-：无报告病例 —— 报告管辖区域未向CDC提交任何病例。
N：不可报告 —— 在报告管辖区域，该疾病或条件根据法律、法规或条例不可报告。
NN：非国家报告 —— 该条件未被指定为国家报告。
NP：国家报告但未发布。
NC：未计算 —— 可用数据不足以支持此统计数据的计算。
Cum：累计当年至今数。
Max：最大值 —— 过去52周内的最大病例数。